Adeleke OA - Search Results

1

Characterization of Prototype Gummy Formulations Provides Insight into Setting Quality Standards.

Adeleke OA, Abedin S. Adeleke OA, et al. AAPS PharmSciTech. 2024 Jul 3;25(6):155. doi: 10.1208/s12249-024-02876-w. AAPS PharmSciTech. 2024. PMID: 38960983

2

A child-friendly anti-infective gummy formulation: Design, physicochemical, micromechanical, and taste sensory evaluation.

Kean EA, Adeleke OA. Kean EA, et al. Among authors: adeleke oa. Drug Deliv Transl Res. 2024 May;14(5):1319-1337. doi: 10.1007/s13346-023-01464-y. Epub 2023 Nov 6. Drug Deliv Transl Res. 2024. PMID: 37930631

3

State of the art in pediatric nanomedicines.

Abedin S, Adeleke OA. Abedin S, et al. Among authors: adeleke oa. Drug Deliv Transl Res. 2024 Sep;14(9):2299-2324. doi: 10.1007/s13346-024-01532-x. Epub 2024 Feb 7. Drug Deliv Transl Res. 2024. PMID: 38324166 Review.

4

Evaluation of the impacts of formulation variables and excipients on the drug release dynamics of a polyamide 6,10-based monolithic matrix using mathematical tools.

Adeleke OA, Choonara YE, Kumar P, du Toit LC, Tomar LK, Tyagi C, Pillay V. Adeleke OA, et al. AAPS PharmSciTech. 2013 Dec;14(4):1349-59. doi: 10.1208/s12249-013-0021-7. Epub 2013 Aug 30. AAPS PharmSciTech. 2013. PMID: 23990121 Free PMC article.

5

Leading Paediatric Infectious Diseases-Current Trends, Gaps, and Future Prospects in Oral Pharmacotherapeutic Interventions.

Rampedi PN, Ogunrombi MO, Adeleke OA. Rampedi PN, et al. Among authors: adeleke oa. Pharmaceutics. 2024 May 26;16(6):712. doi: 10.3390/pharmaceutics16060712. Pharmaceutics. 2024. PMID: 38931836 Free PMC article. Review.

6

Geriatric drug delivery - barriers, current technologies and the road ahead.

Kean EA, Adeleke OA. Kean EA, et al. Among authors: adeleke oa. J Drug Target. 2024 Dec;32(10):1186-1206. doi: 10.1080/1061186X.2024.2386626. Epub 2024 Aug 9. J Drug Target. 2024. PMID: 39076049 Review.

7

In vitro, ex vivo and in silico mechanistic elucidation of the performance of an optimized porosity-controlled multi-elemental transbuccal system.

Adeleke OA, Choonara YE, du Toit LC, Kumar P, Pillay V. Adeleke OA, et al. Pharm Res. 2015 Jul;32(7):2384-409. doi: 10.1007/s11095-015-1631-4. Epub 2015 Jan 29. Pharm Res. 2015. PMID: 25630817

8

A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation.

Rampedi PN, Ogunrombi MO, Wesley-Smith J, Adeleke OA. Rampedi PN, et al. Among authors: adeleke oa. Pharmaceutics. 2022 Dec 25;15(1):64. doi: 10.3390/pharmaceutics15010064. Pharmaceutics. 2022. PMID: 36678693 Free PMC article.

9

Optimal Design, Characterization and Preliminary Safety Evaluation of an Edible Orodispersible Formulation for Pediatric Tuberculosis Pharmacotherapy.

Matawo N, Adeleke OA, Wesley-Smith J. Matawo N, et al. Among authors: adeleke oa. Int J Mol Sci. 2020 Aug 10;21(16):5714. doi: 10.3390/ijms21165714. Int J Mol Sci. 2020. PMID: 32784947 Free PMC article.

10

Nanofibrous Scaffolds for Diabetic Wound Healing.

Yusuf Aliyu A, Adeleke OA. Yusuf Aliyu A, et al. Among authors: adeleke oa. Pharmaceutics. 2023 Mar 19;15(3):986. doi: 10.3390/pharmaceutics15030986. Pharmaceutics. 2023. PMID: 36986847 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters